Multisession radiosurgery for grade 2 (WHO), high risk meningiomas. A phase II clinical trial

PURPOSE: Patients suffering from recurrent and residual grade 2 (WHO) meningiomas after subtotal excision should be considered as high-risk groups with an uncertain prognosis. Adjuvant radiotherapy seems to be the best approach to reduce disease progression. The primary aim of this phase II explorat...

Descripción completa

Detalles Bibliográficos
Autores principales: Marchetti, Marcello, Pinzi, Valentina, Iezzoni, Cecilia, Morlino, Sara, Tramacere, Irene, De Martin, Elena, Cane, Irene, Fariselli, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8979484/
https://www.ncbi.nlm.nih.gov/pubmed/35378640
http://dx.doi.org/10.1007/s11060-022-03978-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8979484/
https://www.ncbi.nlm.nih.gov/pubmed/35378640
http://dx.doi.org/10.1007/s11060-022-03978-w

Ejemplares similares